Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001641172-25-005648
Filing Date
2025-04-22
Accepted
2025-04-22 13:00:51
Documents
12

Document Format Files

Seq Description Document Type Size
1 formprer14a.htm PRER14A 93314
2 formprer14a_001.jpg GRAPHIC 2738
3 formprer14a_002.jpg GRAPHIC 3595
4 formprer14a_003.jpg GRAPHIC 4103
5 formprer14a_004.jpg GRAPHIC 2926
6 formprer14a_005.jpg GRAPHIC 938
7 formprer14a_006.jpg GRAPHIC 921
8 formprer14a_007.jpg GRAPHIC 921
9 formprer14a_008.jpg GRAPHIC 1255
10 formprer14a_009.jpg GRAPHIC 1274
11 proxy_001.jpg GRAPHIC 461787
12 proxy_002.jpg GRAPHIC 207010
  Complete submission text file 0001641172-25-005648.txt   1042589
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 001-41488 | Film No.: 25856651
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)